Suchergebnisse - "Mertens, Daniel"

PubPharm (6)

1

Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors

enthalten in: International journal of cancer | 2022

von Wolf, C. | Maus, C. | Persicke, M. | +8

2

The Phospholipase Cγ2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein

enthalten in: The Journal of biological chemistry | 2016

von Walliser, C. | Hermkes, E. | Schade, A. | +7

3

Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)

enthalten in: Best practice & research. Clinical haematology | 2010

von Zenz, T. | Fröhling, S. | Mertens, D. | +2

4

Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia

enthalten in: Haematologica | 2010

von Zenz, T. | Mertens, D. | Stilgenbauer, S.

CommentOn: Haematologica. 2010 Sep;95(9):1519-25. - PMID 20421269

5

Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes

enthalten in: Blood | 2006

von Kienle, D. | Benner, A. | Kröber, A. | +8

6

Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2005

von Kienle, D. | Korz, C. | Hosch, B. | +8

1
[1]